The U.S. Food and Drug Administration announced approval of vaccines for the 2010-2011 influenza season in the United States. The FDA noted that each year, “experts from FDA, World Health Organization, CDC, and other institutions study virus samples and patterns collected worldwide to identify strains likely to cause the most illness during the upcoming season. Based on that information and the recommendations of FDA’s Vaccines and Related Biological Products Advisory Committee, manufacturers are including the respective three strains in the 2010-2011 vaccines:

– A/California/7/09 (H1N1)-like virus (pandemic (H1N1) 2009 influenza virus)

– A/Perth /16/2009 (H3N2)-like virus

– B/Brisbane/60/2008-like virus

The brand names and manufacturers for the upcoming season’s vaccines are: Afluria, CSL Limited; Agriflu, Novartis Vaccines and Diagnostics; Fluarix, GlaxoSmithKline Biologicals; FluLaval, ID Biomedical Corporation; FluMist, MedImmune Vaccines Inc.; Fluvirin, Novartis Vaccines and Diagnostics Limited; and Fluzone and Fluzone High-Dose, Sanofi Pasteur Inc.

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm220718.htm